Buyout

The $37bn investment arm of Denmark’s Novo Nordisk Foundation is building a roster of homegrown GPs in Asia and growing its regional headcount, says managing partner Amit Kakar.

As deploying capital gets harder, lenders and lawyers are turning to hybrid structures that blend sub-line mechanics with parallel vehicles and squeezing more leverage out of uncalled commitments.

Global macroeconomic concerns have pushed more investors towards Europe, leaving the UK to take a larger share of activity.

The private equity model isn’t broken, but the illusion of uniform success is, writes Scott Hart, partner and chief executive at StepStone Group.

The combination of the two firms, which will create the world's largest healthcare private equity investor, will change how healthcare investing is done by linking East and West opportunities, its co-chief executives tell PEI.

After a surge in interest around the covid-19 pandemic, it has been a mixed picture for life sciences and biotech-focused PE fundraising and capital deployment.

GPs have to generate more cashflow and up their value creation game to make deals work, according to Bain & Co's Global Private Equity Report 2026.

The Tokyo Stock Exchange is increasing minimum market capitalisation for companies listed in its Growth Market section to ¥10bn by 2030.

The firm reportedly paused a multi-asset CV involving this asset in 2023.

Japan is KKR’s second-largest private equity investment destination, with India also in the top four, co-chief Joseph Bae told an HKMA event in Hong Kong.